+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07708545

Comparing Tegoprazan and Lansoprazole for Healing Bleeding Peptic Ulcers A Randomized, Double-Blind Study with 14-Day Treatment Evaluating Upper Gastrointestinal Ulcer Recovery

Led by Universitas Indonesia · Updated on 2026-08-21

162

Participants Needed

3

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing two medicines, tegoprazan and lansoprazole, to see which is better at healing bleeding peptic ulcers after 2 weeks of treatment in people in Indonesia. This study addresses a gap by directly comparing these two drugs, which work differently to reduce stomach acid, in a head-to-head trial. Peptic ulcer disease affects many people worldwide, and tegoprazan is a newer type of acid blocker that may work faster than traditional treatments like lansoprazole. Participants receive initial care including IV fluids, blood transfusions if needed, and high-dose acid-reducing medicine for the first 72 hours. Within 24 hours of hospital admission, they undergo a gastroscopy to examine the stomach and receive endoscopic hemostatic therapy if necessary. They are then randomly assigned to take either a 50 mg tegoprazan tablet plus a lansoprazole placebo, or a 30 mg lansoprazole capsule plus a tegoprazan placebo daily, 30 minutes before breakfast, for 14 days. If testing shows infection with H. pylori, participants receive additional antibiotic treatment. After 14 days, a second gastroscopy checks ulcer healing. During the study, participants are monitored daily for symptoms and rebleeding. They are reminded to take their medication and attend the follow-up gastroscopy, with contact made if needed. Researchers evaluate ulcer healing by comparing gastroscopy images taken before and after treatment. The main outcome measured is the mucosal healing rate on day 15 after starting treatment, with rebleeding rates also assessed within 14 days. The study lasts about 2 weeks of treatment plus follow-up evaluations.

CONDITIONS

Brief Title

Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic Ulcers

Research Team

D

dr. Hasan Maulahela, Sp.PD-KGEH, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here